Management of non-motor complications in Parkinson's disease

被引:10
|
作者
Fujimoto, Ken-ichi [1 ]
机构
[1] Jichi Med Univ, Dept Neurol, Shimotsuke, Tochigi 3290498, Japan
关键词
Psychosis; Mianserin hydrochloride; Deep brain stimulation; Leg-holding exercise; Mood disorders; RISK-FACTORS; DOUBLE-BLIND; PSYCHOSIS; HALLUCINATIONS; DYSREGULATION; QUETIAPINE; DISORDERS; MIANSERIN; DRUGS;
D O I
10.1007/s00415-009-5245-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This paper summarizes the methods we devised for the treatment of psychosis, orthostatic hypotension, and mood disorders among the various non-motor complications of Parkinson's disease. Psychosis may not manifest when a patient believes in his/her delusions. If left untreated over a prolonged period, however, the delusions progress to paranoia that is very difficult to cure. Accordingly, enquiries should be made during routine examinations to detect the presence of psychosis and facilitate early discovery. Atypical antipsychotics are used when psychosis does not improve after reducing the doses of antiparkinson drugs. We achieved favorable results by using mianserin hydrochloride prior to this step, with efficacy being observed for hallucinations and mild delusions that often manifested at night. This drug does not act as a dopamine receptor blocker, so it has the advantage of not aggravating motor symptoms. With this therapy, it is also possible to improve motor symptoms without inducing psychosis by reducing the doses of antiparkinson drugs and locally stimulating the motor loop by deep brain stimulation of the subthalamic nucleus. We previously introduced leg-holding exercises for the treatment of orthostatic hypotension, through which blood pooled in the veins is returned to the systemic circulation by holding the knees. This can be done easily and is free of adverse reactions. Mood disorders are difficult to cope with in patients with Parkinson's disease, but may be treated by selecting an appropriate dopamine agonist while giving consideration to affinity for the dopamine D3 receptor. However, treatment becomes complicated when the dopamine receptor is overstimulated. Here we report on cases of successfully treated pathological gambling and dopamine dysregulation syndrome, which are considered difficult to manage. The solution may differ depending on a patient's environment, and it is not easy to prescribe therapy based on evidence-based medicine. The best therapy should be selected by maintaining communication with the patient and developing a relationship built on trust.
引用
收藏
页码:S299 / S305
页数:7
相关论文
共 50 条
  • [1] Management of non-motor complications in Parkinson’s disease
    Ken-ichi Fujimoto
    [J]. Journal of Neurology, 2009, 256 : 299 - 305
  • [2] Management for motor and non-motor complications in late Parkinson's disease
    Chan, Daniel K. Y.
    Cordato, Dennis J.
    O'Rourke, Fintan
    [J]. GERIATRICS-US, 2008, 63 (05): : 22 - 27
  • [3] Management of Motor and Non-Motor Symptoms in Parkinson’s Disease
    Fabienne Sprenger
    Werner Poewe
    [J]. CNS Drugs, 2013, 27 : 259 - 272
  • [4] Management of Motor and Non-Motor Symptoms in Parkinson's Disease
    Sprenger, Fabienne
    Poewe, Werner
    [J]. CNS DRUGS, 2013, 27 (04) : 259 - 272
  • [5] A case study on non-motor complications in Parkinson's disease patients
    Hin Ming, J. L.
    King, T. E.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S653 - S653
  • [6] Evaluation and management of the non-motor features of Parkinson's disease
    Wishart, Steven
    Macphee, Graeme J. A.
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (02) : 69 - 85
  • [7] Non-motor symptoms of Parkinson's disease: diagnosis and management
    Chaudhuri, KR
    Healy, DG
    Schapira, AHV
    [J]. LANCET NEUROLOGY, 2006, 5 (03): : 235 - 245
  • [8] Non-motor complications in late stage Parkinson's disease: recognition, management and unmet needs
    Rukavina, Katarina
    Batzu, Lucia
    Boogers, Alexandra
    Abundes-Corona, Arturo
    Bruno, Veronica
    Chaudhuri, K. Ray
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (03) : 335 - 352
  • [9] Identification and management of non-motor aspects in Parkinson's disease
    Heath, SL
    [J]. MOVEMENT DISORDERS, 2006, 21 : S22 - S22
  • [10] Ladasten in the management of non-motor symptoms of Parkinson's disease
    Sarycheva, T. N.
    Rybak, V. A.
    Kurushina, O. V.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (01) : 85 - 87